Article metrics
PDF
Other content recommended for you
- Photodynamic therapy for steroid-associated central serous chorioretinopathy
- Retinal and choroidal changes observed with ‘En face’ enhanced-depth imaging OCT in central serous chorioretinopathy
- Two-year follow-up of mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy
- Optical coherence tomography angiography of flat irregular pigment epithelial detachments in central serous chorioretinopathy
- Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study
- Spironolactone versus observation in the treatment of acute central serous chorioretinopathy
- Discrepancy in current central serous chorioretinopathy classification
- Long-term efficacy of half-dose photodynamic therapy on chronic central serous chorioretinopathy
- Mimics and chameleons of optic neuritis
- Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level